missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 30302393

CDX2 Antibody (CL12974) [DyLight 650], Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP3-18552C

Product Code. 30302393

  • 770.00€ / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

CDX2 Monoclonal antibody specifically detects CDX2 in Human samples. It is validated for Immunohistochemistry,Western Blot,Immunohistochemistry (Paraffin),Immunocytochemistry/ Immunofluorescence
TRUSTED_SUSTAINABILITY
Specifications

Specifications

CDX2
Monoclonal
DyLight 650
caudal type homeo box transcription factor 2, caudal type homeobox 2, Caudal-type homeobox protein 2, CDX-3, CDX3caudal type homeobox transcription factor 2, homeobox protein CDX-2
This antibody was developed using a synthetic peptide derived from Q99626, with the exact immunogen sequence remaining proprietary.
0.1 mL
Cancer, Chromatin Research, DNA Repair, Growth and Development, Transcription Factors and Regulators
1045
Store at 4⪚C in the dark.
IgG1
Immunohistochemistry, Western Blot, Immunohistochemistry (Paraffin), Immunocytochemistry/Immunofluorescence
CL12974
50mM Sodium Borate
Mouse
Protein A purified
RUO
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.